** Shares of India's Entero Healthcare Solutions ENTE.NS drop 3% to 1,303 rupees
** Jefferies downgrades stock to "hold" from "buy", cuts price target by 20% to 1,320 rupees
** Stock has an average rating of "buy" with median PT of 1,481 rupees - data compiled by LSEG
** Drugmaker's Q4 revenue and profit after tax jump 29% and 23%, respectively, over the year earlier
** Jefferies says company's Q4 profit and revenue came in 6% below its estimates and FY26 forecast was "lower than expected"
** Brokerage estimates 34% revenue growth in FY26, while company forecasts more than 30% increase
** Jefferies flags slower-than-expected pace of acquisitions, sluggish organic growth and says company's expectation setting and meeting those has been "checkered" so far
** Stock down ~9% YTD
(Reporting by Hritam Mukherjee in Bengaluru)
((Hritam.Mukherjee@thomsonreuters.com;))